← Leaderboards
Maureen E Murphy
Wistar Institute
$37,408,887
Attributed
$37,408,887
Total exposure
15
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$29,576,728 · 14
CDC$7,832,159 · 1
By mechanism
R01$19,057,014 · 6
U52$7,832,159 · 1
T32$5,821,673 · 1
P01$3,470,205 · 3
S10$788,255 · 2
P30$289,416 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorApoptosisCellsMediatingMutationPathway InteractionsProteinsGenesCancer TherapyMouse ModelIn VivoVariantCancer RiskGenetic TranscriptionTp53 GeneResponsePharmaceutical PreparationsAllelesCell LineTumor Suppressor ProteinsTumor SuppressionMutantNeoplastic Cell
Grant awards (98)
The genetics of tumor suppression by p53$401,611
R01 · FY2025 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$391,227
R01 · FY2025 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$95,992
R01 · FY2025 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$55,851
P30 · FY2025 · CA · contact PI
The impact of coding region variants on mutant p53 biology$422,619
R01 · FY2024 · CA · contact PI
The genetics of tumor suppression by p53$381,531
R01 · FY2024 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$371,666
R01 · FY2024 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$90,413
R01 · FY2024 · CA · contact PI
The genetics of tumor suppression by p53 - Diversity Supplement$72,736
R01 · FY2024 · CA · contact PI
Targeting HSP70 for MelanomaTherapy$446,169
P01 · FY2023 · CA · contact PI
The impact of coding region variants on mutant p53 biology$435,965
R01 · FY2023 · CA · contact PI
The genetics of tumor suppression by p53$422,186
R01 · FY2023 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$391,227
R01 · FY2023 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$47,390
P30 · FY2023 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants - Diversity Supplement$43,681
R01 · FY2023 · CA · contact PI
Purchase of a SARRP 200 Platform for Irradiation$600,000
S10 · FY2022 · OD · contact PI
Training Program in Basic Cancer Research$537,584
T32 · FY2022 · CA · contact PI
Targeting HSP70 for MelanomaTherapy$455,537
P01 · FY2022 · CA · contact PI
The impact of coding region variants on mutant p53 biology$435,965
R01 · FY2022 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$383,402
R01 · FY2022 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$47,390
P30 · FY2022 · CA · contact PI
Training Program in Basic Cancer Research$688,528
T32 · FY2021 · CA · contact PI
Targeting HSP70 for MelanomaTherapy$465,781
P01 · FY2021 · CA · contact PI
The impact of coding region variants on mutant p53 biology$444,800
R01 · FY2021 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$391,227
R01 · FY2021 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$47,390
P30 · FY2021 · CA · contact PI
The impact of coding region variants on mutant p53 biology$484,057
R01 · FY2020 · CA · contact PI
Training Program in Basic Cancer Research$469,453
T32 · FY2020 · CA · contact PI
p53 Variants in Cancer Risk and Therapy$429,501
R01 · FY2020 · CA · contact PI
Targeting HSP70 for MelanomaTherapy$428,529
P01 · FY2020 · CA · contact PI
Functional Analysis of p53 polymorphic variants$384,750
R01 · FY2020 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$44,005
P30 · FY2020 · CA · contact PI
Training Program in Basic Cancer Research$544,673
T32 · FY2019 · CA · contact PI
Targeting HSP70 for Melanoma Therapy$481,458
P01 · FY2019 · CA · contact PI
HSP70 and melanoma$426,316
R01 · FY2019 · CA · contact PI
p53 Variants in Cancer Risk and Therapy$416,042
R01 · FY2019 · CA · contact PI
Functional Analysis of p53 polymorphic variants$373,207
R01 · FY2019 · CA · contact PI
Research Program: Molecular and Cellular Oncogenesis$47,390
P30 · FY2019 · CA · contact PI
Training Program in Basic Cancer Research$548,195
T32 · FY2018 · CA · contact PI
HSP70 and melanoma$439,502
R01 · FY2018 · CA · contact PI
p53 Variants in Cancer Risk and Therapy$428,330
R01 · FY2018 · CA · contact PI
Functional Analysis of p53 polymorphic variants$384,750
R01 · FY2018 · CA · contact PI
The role of p53 in Iron Overload$150,165
R21 · FY2018 · HL · contact PI
Training Program in Basic Cancer Research$591,366
T32 · FY2017 · CA · contact PI
HSP70 and melanoma$439,502
R01 · FY2017 · CA · contact PI
p53 Variants in Cancer Risk and Therapy$421,358
R01 · FY2017 · CA · contact PI
Functional Analysis of p53 polymorphic variants$384,750
R01 · FY2017 · CA · contact PI
HSP70 as a Novel Therapeutic Target for Melanoma$236,081
P01 · FY2017 · CA · contact PI
Purchase of a Seahorse Bioscience XF Analyzer$188,255
S10 · FY2017 · OD · contact PI
Training Program in Basic Cancer Research$11,879
T32 · FY2017 · CA · contact PI
Training Program in Basic Cancer Research$648,137
T32 · FY2016 · CA · contact PI
p53 Variants in Cancer Risk and Therapy$466,358
R01 · FY2016 · CA · contact PI
HSP70 and melanoma$439,502
R01 · FY2016 · CA · contact PI
Functional Analysis of p53 polymorphic variants$384,750
R01 · FY2016 · CA · contact PI
HSP70 as a Novel Therapeutic Target for Melanoma$235,803
P01 · FY2016 · CA · contact PI
Training Program in Basic Cancer Research$614,229
T32 · FY2015 · CA · contact PI
HSP70 and melanoma$462,002
R01 · FY2015 · CA · contact PI
HSP70 as a Novel Therapeutic Target for Melanoma$236,006
P01 · FY2015 · CA · contact PI
Training Program in Basic Cancer Research$623,106
T32 · FY2014 · CA · contact PI
The ARF Tumor Suppressor$361,188
R01 · FY2014 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$335,745
R01 · FY2014 · CA · contact PI
HSP70 as a Novel Therapeutic Target for Melanoma$235,512
P01 · FY2014 · CA · contact PI
Training Program in Basic Cancer Research$544,523
T32 · FY2013 · CA · contact PI
The ARF Tumor Suppressor$325,422
R01 · FY2013 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$302,498
R01 · FY2013 · CA · contact PI
HSP70 as a Novel Therapeutic Target for Melanoma$249,329
P01 · FY2013 · CA · contact PI
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade$1,158,894
U52 · FY2012 · PS · contact PI
The ARF Tumor Suppressor$340,759
R01 · FY2012 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$316,755
R01 · FY2012 · CA · contact PI
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade$1,174,948
U52 · FY2011 · PS · contact PI
The ARF Tumor Suppressor$351,225
R01 · FY2011 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$326,484
R01 · FY2011 · CA · contact PI
Tuberculosis Surveillance, Prevention and Control, and Laboratory Upgrade$1,211,074
U52 · FY2010 · PS · contact PI
The ARF Tumor Suppressor$362,088
R01 · FY2010 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$336,581
R01 · FY2010 · CA · contact PI
TUBERCULOSIS ELIMINATION AND LABORATORY$1,123,550
U52 · FY2009 · PS · contact PI
TUBERCULOSIS ELIMINATION AND LABORATORY$1,123,551
U52 · FY2008 · PS · contact PI
Functional Analysis of p53 Polymorphic Variants$316,480
R01 · FY2008 · CA · contact PI
p53-Mediated Transcription and Apoptosis$288,437
R01 · FY2008 · CA · contact PI
PS05-003 TUBERCULOSIS ELIMINATION AND LABORATORY$975,813
U52 · FY2007 · PS · contact PI
Functional Analysis of p53 Polymorphic Variants$316,480
R01 · FY2007 · CA · contact PI
p53-Mediated Transcription and Apoptosis$288,437
R01 · FY2007 · CA · contact PI
TUBERCULOSIS ELIMINATION AND LABORATORY$1,064,329
U52 · FY2006 · PS · contact PI
Functional Analysis of p53 Polymorphic Variants$307,302
R01 · FY2006 · CA · contact PI
p53-Mediated Transcription and Apoptosis$297,051
R01 · FY2006 · CA · contact PI
Functional Analysis of p53 Polymorphic Variants$317,567
R01 · FY2005 · CA
p53-Mediated Transcription and Apoptosis$304,200
R01 · FY2005 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2005 · PS
p53-Mediated Transcription and Apoptosis$301,590
R01 · FY2004 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2004 · PS
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS$266,361
R01 · FY2003 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2003 · PS
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS$258,605
R01 · FY2002 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2002 · PS
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS$251,075
R01 · FY2001 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2001 · PS
TRANSCRIPTIONAL REPRESSION AND P53 DEPENDENT APOPTOSIS$243,759
R01 · FY2000 · CA
TUBERCULOSIS ELIMINATION AND LABORATORY$0
U52 · FY2000 · PS